Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Ward

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
The American Journal of Medicine|March 1, 1996
Prospective trial of paromomycin for cryptosporidiosis in AIDST P Flanigan, B Ramratnam, C Graeber, et al.
AIDS (London, England)|August 16, 2001
Clinical assessment of HIV-associated lipodystrophy in an ambulatory populationK A Lichtenstein, D J Ward, A C Moorman, et al.
AIDS Research and Human Retroviruses|November 11, 1999
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patientsM S Saag, W J Fessel, C A Kaufman, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Annals of Epidemiology|September 4, 1999
Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS)A C Moorman, S D Holmberg, S I Marlowe, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The American Journal of Medicine|March 1, 1996
Prospective trial of paromomycin for cryptosporidiosis in AIDST P Flanigan, B Ramratnam, C Graeber, et al.
AIDS (London, England)|August 16, 2001
Clinical assessment of HIV-associated lipodystrophy in an ambulatory populationK A Lichtenstein, D J Ward, A C Moorman, et al.
AIDS Research and Human Retroviruses|November 11, 1999
Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patientsM S Saag, W J Fessel, C A Kaufman, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Annals of Epidemiology|September 4, 1999
Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS)A C Moorman, S D Holmberg, S I Marlowe, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
Pageof 11